{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:18:54Z","timestamp":1793744334970,"version":"4.6.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,23]],"date-time":"2023-07-23T00:00:00Z","timestamp":1690070400000},"content-version":"vor","delay-in-days":203,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012176","name":"Maudsley Charity","doi-asserted-by":"publisher","award":["094849\/Z\/10\/Z"],"award-info":[{"award-number":["094849\/Z\/10\/Z"]}],"id":[{"id":"10.13039\/100012176","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["666"],"award-info":[{"award-number":["666"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["ACF-2019-14-004"],"award-info":[{"award-number":["ACF-2019-14-004"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.nicl.2023.103481","type":"journal-article","created":{"date-parts":[[2023,7,24]],"date-time":"2023-07-24T20:14:13Z","timestamp":1690229653000},"page":"103481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Reward processing in schizophrenia and its relation to Mu opioid receptor availability and negative symptoms: A [11C]-carfentanil PET and fMRI study"],"prefix":"10.1016","volume":"39","author":[{"given":"Ekaterina","family":"Shatalina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishekh H.","family":"Ashok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Nour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Reis Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenii A.","family":"Rabiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver D.","family":"Howes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.nicl.2023.103481_b0005","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0920-9964(90)90005-R","article-title":"A depression rating scale for schizophrenics","volume":"3","author":"Addington","year":"1990","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.nicl.2023.103481_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-12366-4","article-title":"Reduced mu opioid receptor availability in schizophrenia revealed with [11C]-carfentanil positron emission tomographic Imaging","volume":"10","author":"Ashok","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nicl.2023.103481_b0015","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00210-002-0533-2","article-title":"Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice","volume":"365","author":"Becker","year":"2002","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"issue":"4265","key":"10.1016\/j.nicl.2023.103481_b0020","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1126\/science.185694","article-title":"Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness","volume":"194","author":"Bloom","year":"1976","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.nicl.2023.103481_b0025","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.biopsych.2019.05.012","article-title":"The role of dynorphin and the kappa opioid receptor in the symptomatology of schizophrenia: a review of the evidence","volume":"86","author":"Clark","year":"2019","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.nicl.2023.103481_b0030","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.biopsych.2012.01.027","article-title":"Endogenous opioid release in the human brain reward system induced by acute amphetamine administration","volume":"72","author":"Colasanti","year":"2012","journal-title":"Biol. Psychiatry"},{"issue":"4","key":"10.1016\/j.nicl.2023.103481_b0035","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/15563657708988200","article-title":"Morphine as an antipsychotic?","volume":"11","author":"Comfort","year":"1977","journal-title":"Clin. Toxicol."},{"issue":"3","key":"10.1016\/j.nicl.2023.103481_b0040","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.conb.2004.05.005","article-title":"Mu opioid receptor: a gateway to drug addiction","volume":"14","author":"Contet","year":"2004","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.nicl.2023.103481_b0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.schres.2016.10.004","article-title":"Computational approaches to schizophrenia: a perspective on negative symptoms","volume":"186","author":"Deserno","year":"2017","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.nicl.2023.103481_b0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00004728-198503000-00001","article-title":"Imaging opiate receptors in the human brain by positron tomography","volume":"9","author":"Frost","year":"1985","journal-title":"J. Comput. Assist. Tomogr."},{"issue":"8","key":"10.1016\/j.nicl.2023.103481_b0055","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S2215-0366(18)30050-6","article-title":"Negative symptoms of schizophrenia: new developments and unanswered research questions","volume":"5","author":"Galderisi","year":"2018","journal-title":"Lancet Psychiatry"},{"issue":"6","key":"10.1016\/j.nicl.2023.103481_b0060","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jrp.2005.11.001","article-title":"Anticipatory and consummatory components of the experience of pleasure: a scale development study","volume":"40","author":"Gard","year":"2006","journal-title":"J. Res. Pers."},{"key":"10.1016\/j.nicl.2023.103481_b0065","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archgenpsychiatry.2011.1269","article-title":"Negative symptoms and the failure to represent the expected reward value of actions: behavioral and computational modeling evidence","volume":"69","author":"Gold","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.nicl.2023.103481_b0070","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1006\/nimg.2001.0880","article-title":"Improved detection of event-related functional MRI signals using probability functions","volume":"14","author":"Hagberg","year":"2001","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2023.103481_b0075","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s002130000622","article-title":"Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice","volume":"154","author":"Hall","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"10.1016\/j.nicl.2023.103481_b0080","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/BF02532374","article-title":"Laminar distribution of the multiple opioid receptors in the human cerebral cortex","volume":"21","author":"Hiller","year":"1996","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nicl.2023.103481_b0085","series-title":"Solutions Manual: Applied Statistics for the Behavioral Sciences","author":"Hinkle","year":"1988"},{"key":"10.1016\/j.nicl.2023.103481_b0090","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00259-008-0935-6","article-title":"Measurement of central mu-opioid receptor binding in vivo with PET and [11C]carfentanil: a test-retest study in healthy subjects","volume":"36","author":"Hirvonen","year":"2009","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"7069","key":"10.1016\/j.nicl.2023.103481_b0095","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nature04172","article-title":"Morphine reward in dopamine-deficient mice","volume":"438","author":"Hnasko","year":"2005","journal-title":"Nature"},{"issue":"4265","key":"10.1016\/j.nicl.2023.103481_b0100","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1126\/science.185695","article-title":"The C-fragment of \u03b2-lipotropin: an endogenous neuroleptic or antipsychotogen?","volume":"194","author":"Jacquet","year":"1976","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.nicl.2023.103481_b0105","doi-asserted-by":"crossref","first-page":"e0255292","DOI":"10.1371\/journal.pone.0255292","article-title":"Brain activations associated with anticipation and delivery of monetary reward: A systematic review and meta-analysis of fMRI studies","volume":"16","author":"Jauhar","year":"2021","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.nicl.2023.103481_b0110","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00213-006-0405-4","article-title":"Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics","volume":"187","author":"Juckel","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.nicl.2023.103481_b0115","doi-asserted-by":"crossref","first-page":"107704","DOI":"10.1016\/j.neuropharm.2019.107704","article-title":"Antipsychotics: mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology","volume":"172","author":"Kaar","year":"2020","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.nicl.2023.103481_b0120","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/j.1460-9568.2004.03581.x","article-title":"Mu-opioid receptor knockout mice show diminished food-anticipatory activity","volume":"20","author":"Kas","year":"2004","journal-title":"Eur. J. Neurosci."},{"issue":"2","key":"10.1016\/j.nicl.2023.103481_b0125","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.nicl.2023.103481_b0130","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.schres.2017.09.034","article-title":"Combining actigraphy, ecological momentary assessment and neuroimaging to study apathy in patients with schizophrenia","volume":"195","author":"Kluge","year":"2018","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.nicl.2023.103481_b0135","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1006\/nimg.2000.0593","article-title":"FMRI visualization of brain activity during a monetary incentive delay task","volume":"12","author":"Knutson","year":"2000","journal-title":"Neuroimage"},{"issue":"3","key":"10.1016\/j.nicl.2023.103481_b0140","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","article-title":"Simplified reference tissue model for PET receptor studies","volume":"4","author":"Lammertsma","year":"1996","journal-title":"Neuroimage"},{"key":"10.1016\/j.nicl.2023.103481_b0145","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.schres.2019.12.041","article-title":"Reward anticipation in schizophrenia: a coordinate-based meta-analysis","volume":"218","author":"Leroy","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.nicl.2023.103481_b0150","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.neubiorev.2021.11.032","article-title":"New and emerging treatments for schizophrenia: a narrative review of their pharmacology, efficacy and side effect profile relative to established antipsychotics","volume":"132","author":"Lobo","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nicl.2023.103481_b0155","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fnbeh.2014.00430","article-title":"State-dependent mu-opioid modulation of social motivation","volume":"8","author":"Loseth","year":"2014","journal-title":"Front. Behav. Neurosci."},{"issue":"12","key":"10.1016\/j.nicl.2023.103481_b0160","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1017\/S1461145714000704","article-title":"Amphetamine induced endogenous opioid release in the human brain detected with [(1)(1)C]carfentanil PET: replication in an independent cohort","volume":"17","author":"Mick","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"7","key":"10.1016\/j.nicl.2023.103481_b0165","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/npp.2015.340","article-title":"Blunted endogenous opioid release following an oral amphetamine challenge in pathological gamblers","volume":"41","author":"Mick","year":"2016","journal-title":"Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology"},{"key":"10.1016\/j.nicl.2023.103481_b0170","first-page":"1983","volume":"304","author":"Moles","year":"2004","journal-title":"Deficit in attachment behavior in mice lacking the mu-opioid receptor gene. Science"},{"issue":"8","key":"10.1016\/j.nicl.2023.103481_b0175","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1017\/S0033291714002943","article-title":"Is avolition in schizophrenia associated with a deficit of dorsal caudate activity? A functional magnetic resonance imaging study during reward anticipation and feedback","volume":"45","author":"Mucci","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.nicl.2023.103481_b0180","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1001\/archgenpsychiatry.2012.847","article-title":"Improvement of brain reward abnormalities by antipsychotic monotherapy in schizophrenia","volume":"69","author":"Nielsen","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"issue":"1","key":"10.1016\/j.nicl.2023.103481_b0185","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1177\/1550059417744120","article-title":"Negative symptoms and reward disturbances in schizophrenia before and after antipsychotic monotherapy","volume":"49","author":"Nielsen","year":"2018","journal-title":"Clin. EEG Neurosci."},{"issue":"9-10","key":"10.1016\/j.nicl.2023.103481_b0190","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s00213-017-4582-0","article-title":"Endogenous opioid system: a promising target for future smoking cessation medications","volume":"234","author":"Norman","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.nicl.2023.103481_b0195","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41467-018-03848-y","article-title":"mu-opioid receptor system mediates reward processing in humans","volume":"9","author":"Nummenmaa","year":"2018","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.nicl.2023.103481_b0200","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1002\/hbm.24184","article-title":"The anticipation and outcome phases of reward and loss processing: a neuroimaging meta-analysis of the monetary incentive delay task","volume":"39","author":"Oldham","year":"2018","journal-title":"Hum Brain Mapp"},{"key":"10.1016\/j.nicl.2023.103481_b0205","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1111\/j.1460-9568.2007.05595.x","article-title":"Decreased motivation to eat in mu-opioid receptor-deficient mice","volume":"25","author":"Papaleo","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nicl.2023.103481_b0210","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S1461145707008322","article-title":"Sensorimotor gating and attentional set-shifting are improved by the \u03bc-opioid receptor agonist morphine in healthy human volunteers","volume":"11","author":"Quednow","year":"2008","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.nicl.2023.103481_b0215","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.biopsych.2016.12.029","article-title":"Nalmefene reduces reward anticipation in alcohol dependence: an experimental functional magnetic resonance imaging study","volume":"81","author":"Quelch","year":"2017","journal-title":"Biol. Psychiatry"},{"issue":"8","key":"10.1016\/j.nicl.2023.103481_b0220","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/mp.2011.29","article-title":"Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans","volume":"16","author":"Rabiner","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nicl.2023.103481_b0225","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/jamapsychiatry.2015.2196","article-title":"Ventral striatal activation during reward processing in psychosis: a neurofunctional meta-analysis","volume":"72","author":"Radua","year":"2015","journal-title":"JAMA Psychiat."},{"issue":"10","key":"10.1016\/j.nicl.2023.103481_b0230","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1002\/hbm.24224","article-title":"Aerobic exercise modulates anticipatory reward processing via the \u03bc-opioid receptor system","volume":"39","author":"Saanijoki","year":"2018","journal-title":"Hum. Brain Mapp."},{"issue":"4","key":"10.1016\/j.nicl.2023.103481_b0235","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s00213-007-1016-4","article-title":"Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine","volume":"196","author":"Schlagenhauf","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"10.1016\/j.nicl.2023.103481_b0240","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/0006-3223(85)90179-9","article-title":"Dopamine and the action of opiates: a reevaluation of the dopamine hypothesis of schizophrenia with special consideration of the role of endogenous opioids in the pathogenesis of schizophrenia","volume":"20","author":"Schmauss","year":"1985","journal-title":"Biol. Psychiatry"},{"issue":"52","key":"10.1016\/j.nicl.2023.103481_b0245","doi-asserted-by":"crossref","first-page":"14311","DOI":"10.1523\/JNEUROSCI.2058-08.2008","article-title":"Mesolimbic functional magnetic resonance imaging activations during reward anticipation correlate with reward-related ventral striatal dopamine release","volume":"28","author":"Schott","year":"2008","journal-title":"J. Neurosci."},{"issue":"9-10","key":"10.1016\/j.nicl.2023.103481_b0250","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00213-016-4522-4","article-title":"Feeding-modulatory effects of mu-opioids in the medial prefrontal cortex: a review of recent findings and comparison to opioid actions in the nucleus accumbens","volume":"234","author":"Selleck","year":"2017","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"10.1016\/j.nicl.2023.103481_b0255","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1038\/s41386-022-01316-2","article-title":"Neural responses to reward anticipation and feedback in adult and adolescent cannabis users and controls","volume":"47","author":"Skumlien","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.nicl.2023.103481_b0260","first-page":"219","article-title":"The effects of acute cannabis with and without cannabidiol on neural reward anticipation in adults and adolescents","volume":"8","author":"Skumlien","year":"2023","journal-title":"Biological Psychiatry: Cognitive Neuroscience and Neuroimaging"},{"issue":"Suppl 2","key":"10.1016\/j.nicl.2023.103481_b0265","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1093\/schbul\/sbt197","article-title":"A review of reward processing and motivational impairment in schizophrenia","volume":"40","author":"Strauss","year":"2014","journal-title":"Schizophr Bull"},{"issue":"3","key":"10.1016\/j.nicl.2023.103481_b0270","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0304-3940(76)90086-0","article-title":"Increased CSF levels of endorphines in chronic psychosis","volume":"3","author":"Terenius","year":"1976","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.1016\/j.nicl.2023.103481_b0275","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/s41380-018-0107-4","article-title":"Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals","volume":"25","author":"Turton","year":"2020","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.nicl.2023.103481_b0280","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuroimage.2010.06.044","article-title":"Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy","volume":"54","author":"Tziortzi","year":"2011","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.nicl.2023.103481_b0285","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00213-009-1586-4","article-title":"Altered reward functions in patients on atypical antipsychotic medication in line with the revised dopamine hypothesis of schizophrenia","volume":"206","author":"Walter","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"4","key":"10.1016\/j.nicl.2023.103481_b0290","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s11065-018-9385-5","article-title":"The neural substrate of reward anticipation in health: a meta-analysis of fMRI findings in the monetary incentive delay task","volume":"28","author":"Wilson","year":"2018","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.nicl.2023.103481_b0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-022-02201-8","article-title":"Neural substrates of reward anticipation and outcome in schizophrenia: a meta-analysis of fMRI findings in the monetary incentive delay task","volume":"12","author":"Zeng","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"3","key":"10.1016\/j.nicl.2023.103481_b0300","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1007\/s11682-015-9457-6","article-title":"Mapping anhedonia-specific dysfunction in a transdiagnostic approach: an ALE meta-analysis","volume":"10","author":"Zhang","year":"2016","journal-title":"Brain Imaging Behav."}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158223001729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158223001729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:47:43Z","timestamp":1761972463000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158223001729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":60,"alternative-id":["S2213158223001729"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2023.103481","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reward processing in schizophrenia and its relation to Mu opioid receptor availability and negative symptoms: A [11C]-carfentanil PET and fMRI study","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2023.103481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103481"}}